Tower Research Capital (TRC)’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-90
Closed 6778
2022
Q4
$0 Sell
90
-8,744
-99% -$1.18K ﹤0.01% 6763
2022
Q3
$3K Buy
+8,834
New +$7.75K ﹤0.01% 5490
2022
Q2
Sell
-4,814
Closed -$12K 6906
2022
Q1
$12K Buy
4,814
+3,593
+294% +$7.64K ﹤0.01% 4127
2021
Q4
$3K Buy
+1,221
New +$2.51K ﹤0.01% 5559
2021
Q3
Sell
-12,902
Closed -$29K 6426
2021
Q2
$29K Sell
12,902
-5,901
-31% -$13.6K ﹤0.01% 3553
2021
Q1
$48K Buy
18,803
+18,735
+27,551% +$76.8K ﹤0.01% 3166
2020
Q4
$0 Sell
68
-10,030
-99% -$45.6K ﹤0.01% 5513
2020
Q3
$41K Buy
10,098
+8,739
+643% +$32.9K ﹤0.01% 3623
2020
Q2
$5K Sell
1,359
-3,544
-72% -$9.22K ﹤0.01% 4313
2020
Q1
$9K Sell
4,903
-987
-17% -$3.04K ﹤0.01% 2096
2019
Q4
$23K Buy
+5,890
New +$14.4K ﹤0.01% 1845
2019
Q3
Sell
-842
Closed -$2K 4677
2019
Q2
$2K Sell
842
-4,544
-84% -$12.1K ﹤0.01% 3352
2019
Q1
$14K Sell
5,386
-5,455
-50% -$12.3K ﹤0.01% 2495
2018
Q4
$20K Buy
10,841
+10,205
+1,605% +$24.1K ﹤0.01% 1960
2018
Q3
$2K Sell
636
-8,832
-93% -$28.3K ﹤0.01% 3510
2018
Q2
$37K Buy
9,468
+5,943
+169% +$24.7K ﹤0.01% 2046
2018
Q1
$15K Buy
+3,525
New +$19.2K ﹤0.01% 2318
2017
Q4
Sell
-400
Closed -$1.74K 4205
2017
Q3
$1K Buy
+400
New +$5.39K ﹤0.01% 3696
2017
Q2
Sell
-1,932
Closed -$24K 3660
2017
Q1
$24K Buy
+1,932
New +$28.1K ﹤0.01% 1188
2016
Q3
Sell
-1,315
Closed -$21K 4713
2016
Q2
$21K Buy
1,315
+715
+119% +$10.7K ﹤0.01% 2203
2016
Q1
$9K Buy
+600
New +$9.43K ﹤0.01% 2105
2015
Q4
Sell
-18,412
Closed -$328K 5236
2015
Q3
$328K Buy
18,412
+15,778
+599% +$373K 0.03% 205
2015
Q2
$61K Buy
2,634
+1,696
+181% +$47.6K 0.01% 1213
2015
Q1
$33K Buy
938
+585
+166% +$20K ﹤0.01% 1841
2014
Q4
$12K Buy
353
+315
+829% +$8.44K ﹤0.01% 2017
2014
Q3
$1K Buy
+38
New +$751 ﹤0.01% 4199

Tower Research Capital (TRC)'s OTIC Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Otonomy, Inc. (OTIC) in Q1 2023, closing a stake of 90 shares.

Tower Research Capital (TRC) first reported a position in OTIC in Q3 2014 and held it in 26 quarters. The position peaked at $328K in Q3 2015. 0 funds tracked by Wall St. Rank hold OTIC as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Otonomy, Inc. position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 90 Otonomy, Inc. shares in Q1 2023.
  • Tower Research Capital (TRC) first reported a position in Otonomy, Inc. in Q3 2014 and held it in 26 quarters.
  • Tower Research Capital (TRC)'s Otonomy, Inc. position peaked at $328K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.